The global biologics CDMO market was valued at USD 16.10 Billion in 2023, driven by the rising incidence of chronic diseases across the globe. The market is anticipated to grow at a CAGR of 10.80% during the forecast period of 2024-2032, with the values likely to reach USD 40.52 Billion by 2032.
Base Year
Historical Year
Forecast Year
Biologic contract development and manufacturing organisations (CDMOs) are specialised companies that provide outsourced services for the development and manufacturing of biologic drugs. These organisations support pharmaceutical and biotechnology companies in the production of biologics, which are complex molecules derived from living organisms, such as monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins.
Advancements in Biologics Manufacturing Drive Global Market Expansion
The rising demand for biologics and the need for robust manufacturing infrastructure are key drivers of the market. In September 2024, Eurofins CDMO Alphora announced its plans to build a GMP biologics manufacturing facility in Mississauga, Canada, supported by federal funding and the Strategic Initiative Fund. This facility aims to enhance Canada's capacity for producing monoclonal antibodies and protein therapies for clinical and commercial use. The investment is poised to strengthen the global brain-computer interface (BCI) market by ensuring a stable supply of biologics critical for therapeutic BCI applications, enabling innovation and expanding accessibility during the forecast period.
New Biologics CDMO Ventures to Meet Biologics CDMO Market Demand
The growing demand for plasmid DNA in gene therapies and advanced biologics is shaping the CDMO market. In June 2024, Asahi Kasei Medical’s subsidiary, Bionova Scientific, announced its expansion into plasmid DNA services, establishing a dedicated facility in Texas, USA. This move aligns with the rising demand for biologics CDMOs offering specialised services. The initiative is expected to accelerate the global BCI market growth by enabling the development of cutting-edge therapies that utilise plasmid DNA, fostering innovation in neurotechnology solutions and facilitating their integration into clinical and commercial applications over the forecast period.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Product Type
Market Breakup by Scale
Market Breakup by Region
Monoclonal Antibodies Dominate Biologics CDMO Market Share Growth
The monoclonal antibodies (mAbs) segment dominates the market share by product type due to their widespread use in treating cancer, autoimmune diseases, and infectious diseases. As per the Expert Market Research analysis, the global monoclonal antibodies market is expected to grow at a CAGR of 11.5% during the forecast period of 2024-2032. Increasing demand for targeted therapies, advancements in antibody engineering, and rising approvals for biosimilar mAbs are key drivers. This segment’s robust growth potential ensures its continued market leadership, significantly driving biologics CDMO market expansion during the forecast period through innovation and scalability in production.
North America dominates the market due to advanced healthcare infrastructure, significant investments in biologics manufacturing, and strong R&D activity. The region benefits from a robust pharmaceutical ecosystem, regulatory support, and a focus on innovative therapies such as cell and gene therapies. Future growth is driven by rising demand for biologics and increasing outsourcing trends, positioning North America to sustain market leadership during the forecast period.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Established in 1885 and headquartered in Ingelheim, Germany, Boehringer Ingelheim is a leading pharmaceutical company. In the biologics CDMO sector, it offers comprehensive services, including cell line development, process development, and large-scale manufacturing of therapeutic proteins and antibodies.
Founded in 2010 and based in Wuxi, China, WuXi Biologics is a prominent biologics CDMO. It provides end-to-end...
Established in 2011 and headquartered in Songdo, Incheon, South Korea, Samsung Biologics is a global CDMO. Its...
Founded in 1897 and based in Basel, Switzerland, Lonza is a multinational company serving the pharmaceutical a...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Fujifilm Diosynth Biotechnologies Inc., Toyobo Co. Ltd., Binex Co. Ltd, The Celonic Group, Rentschler Biopharma SE, and AGC Biologics.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Product Type |
|
| Breakup by Scale |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share